- $1.58bn
- $1.82bn
- $3.16bn
- 93
- 82
- 93
- 100
2020 February 28th | 2021 February 26th | 2022 February 25th | 2023 February 24th | 2024 February 23rd | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,724 | 2,596 | 2,773 | 3,233 | 3,160 |
Cost of Revenue | |||||
Gross Profit | 1,215 | 773 | 762 | 922 | 1,017 |
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,467 | 2,553 | 2,753 | 3,167 | 3,042 |
Operating Profit | 257 | 43 | 20.1 | 65.5 | 118 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 245 | 25.9 | 1.6 | 51.6 | 107 |
Provision for Income Taxes | |||||
Net Income After Taxes | 200 | 26.1 | 4 | 35.3 | 81.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 200 | 26.1 | 4 | 35.3 | 81.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 196 | 25.5 | 3.9 | 34 | 78 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.66 | 0.482 | 0.034 | 0.416 | 0.83 |
Dividends per Share |